Elimination of palmitoylation sites in the human dopamine D1 receptor does not affect receptor-G protein interaction

European Journal of Pharmacology

Volumn 324, Issue 1, 1997, Pages 109-116

  Jin, Hui ^a,b   Zastawny, Roman ^a,b   George, Susan R ^a,b   O'Dowd, Brian F ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adenylyl cyclase; Desensitization; Dopamine D1 receptor; Dopaminel; Palmitoylation

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENYLATE CYCLASE; BUTACLAMOL; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; HALOPERIDOL;

ANIMAL CELL; ARTICLE; CELL STRAIN BHK; CONTROLLED STUDY; HUMAN; MUTANT; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ACYLATION; ADENYLATE CYCLASE; ALANINE; AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CLONING, MOLECULAR; CRICETINAE; CYSTEINE; DOPAMINE; DOPAMINE AGONISTS; GTP-BINDING PROTEINS; HUMANS; KIDNEY; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PALMITIC ACID; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, DOPAMINE D1; SEQUENCE ALIGNMENT; SOFTWARE; TRANSFECTION;

EID: 0031564603     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00059-9     Document Type: Article

References (27)

1. Bizzozero, O.A., S.U. Tetzloff and M. Bharadwaj, 1994, Overview: protein palmitoylation in nervous system: current views and unsolved problems, Neurochem. Res. 19, 923.
2. Bonatti, S., G. Migliaccio and K. Simons, 1989, Palmitoylation of viral membrane glycoproteins takes place after exit from the endoplasmic reticulum, J. Biol. Chem. 264, 12590.
3. Bouvier, M., S. Moffett, T.P. Loisel, B. Mouillac, T. Hebert and P. Chidiac, 1995, Palmitoylation of G-protein-coupled receptors: a dynamic modification with functional consequences, Biochem. Soc. Trans. 23, 116.
4. De Lean, A., J.M. Stadel and R.J. Lefkowitz, 1980, A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor, J. Biol. Chem. 255, 7108.
5. Dohlman, H.G., J. Thorner, M.G. Caron and R.J. Lefkowitz, 1991, Model systems for the study of seven-transmembrane-segment receptors, Annu. Rev. Biochem. 60, 653.
6. 2A-adrenergic receptors confers subtype-specific agonist-promoted downregulation, Proc. Natl. Acad. Sci. USA 91, 11178.
7. Higuchi, R., B. Krummel and R.K. Saiki, 1988, A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions, Nucleic Acids Res. 16, 7351.
8. 1 dopamine receptor, J. Neurochem. 65, 1325.
9. Johnson, R. and Y. Salomon, 1991, Assay of adenylyl cyclase catalytic activity, Methods Enzymol. 195, 3.
10. Karnik, S.S., K.D. Ridge, S. Bhattacharya and H.G. Khorana, 1993, Palmitoylation of bovine opsin and its cysteine mutants in COS cells, Proc. Natl. Acad. Sci. USA 90, 40.
11. Kawate, N. and K.M.J. Menon, 1994, Palmitoylation of luteinizing hormone/human choriogonadotropin receptors in transfected cells, J. Biol. Chem. 269, 39651.
12. Kenakin, T., 1995a, Agonist-receptor efficacy. I. Mechanisms of efficacy and receptor promiscuity, Trends Pharmacol. Sci. 16, 188.
13. Kenakin, T., 1995b, Agonist-receptor efficacy. II. Agonist trafficking of receptor signals, Trends Pharmacol. Sci. 16, 232.
14. 2A-adrenergic receptor that eliminate detectable palmitoylation do not perturb receptor-G-protein coupling, J. Biol. Chem. 268, 8003.
15. Milligan, G., R.A. Bond and M. Lee, 1995, Inverse agonism: pharmacological curiosity or potential therapeutic strategy?, Trends Pharmacol. Sci. 16, 10.
16. 341, EMBO J. 12, 349.
17. 1 receptor, Eur. J. Pharmacol. 267, 7.
18. Ng, G.Y.K., S.R. George, R. Zastawny, M. Caron, M. Dennis and B.F. O'Dowd, 1993b, Human serotonin 1B receptor expression in Sf9 cells: phosphorylation, palmitoylation and adenylyl cyclase inhibition, Biochemistry 32, 11727.
19. 2L dopamine receptor in Sf9 cells, J. Neurochem. 63, 1589.
20. Nussenzveig, D.R., M. Heiflink and M.C. Gershengorn, 1993, Agonist-stimulated internalization of the thyrotropin-releasing hormone receptor is dependent on two domains in the receptor carboxyl terminus, J. Biol. Chem. 268, 2389.
21. 2-adrenergic receptor, J. Biol. Chem. 264, 7564.
22. Ovchinnikov, Y.A., N.G. Abdulaev and A.S. Bogachuk, 1988, Two adjacent cysteine residues in the C-terminal cytoplasmic fragment of bovine rhodopsin are palmitoylated, FEBS Lett. 230, 1.
23. 1 receptor pharmacology, ISI Atlas Sci.: Pharmacol. 161.
24. 1 receptor encoded by an intronless gene on chromosome 5, Nature 347, 80.
25. Towler, D.A., J.I. Gordon, S.P. Adams and L. Glaster, 1988, The biology and enzymology of eukaryotic protein acylation, Annu. Rev. Biochem. 57, 69.
26. Van Koppen, C.J. and N.M. Glaster, 1991, The cysteine residue in the carboxyl-terminal domain of the m2 muscarinic acetylcholine receptor is not required for receptor-mediated inhibition of adenylate cyclase, J. Neurochem. 57, 1873.
27. Whaley, B.S., N.Y. Yuan, L. Birnbaumer, L. Clark and R. Barber, 1993, Differential expression of the β-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation, Mol. Pharmacol. 45, 481.